QC
Quantessence Capital Portfolio holdings
AUM
$340M
This Quarter Return
+14.43%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$340M
AUM Growth
+$340M
(-15%)
Cap. Flow
-$64.6M
Cap. Flow
% of AUM
-19.03%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| 1 |
AZEK
The AZEK Co
AZEK
|
$63.6M |
| 2 |
RDFN
Redfin
RDFN
|
$40.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$9.16M |
| 4 |
Insmed
INSM
|
$7.62M |
| 5 |
Sprouts Farmers Market
SFM
|
$7.51M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$30.3M |
| 2 |
The Communication Services Select Sector SPDR Fund
XLC
|
$12.3M |
| 3 |
Exxon Mobil
XOM
|
$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$10.8M |
| 5 |
Pfizer
PFE
|
$10.6M |
Sector Composition
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Technology | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBGS
151
JBG SMITH
JBGS
$1.31B
| $256K | 0.08% |
+14,780
| New | +$256K |
|
152
Opendoor
OPEN
$3.38B
| $255K | 0.08% |
+479,221
| New | +$255K |
|
153
Henry Schein
HSIC
$8.32B
| $252K | 0.07% |
3,455
-21,844
| -86% | -$1.6M |
|
154
AeroVironment
AVAV
$11.8B
| $237K | 0.07% |
+833
| New | +$237K |
|
155
FTI Consulting
FCN
$5.44B
| $235K | 0.07% |
1,457
-943
| -39% | -$152K |
|
156
Huntington Ingalls Industries
HII
$10.6B
| $235K | 0.07% |
+974
| New | +$235K |
|
157
Lincoln Electric
LECO
$13.2B
| $227K | 0.07% |
+1,094
| New | +$227K |
|
158
Nektar Therapeutics
NKTR
$565M
| $223K | 0.07% |
+8,645
| New | +$223K |
|
159
Leidos
LDOS
$23.2B
| $222K | 0.07% |
+1,408
| New | +$222K |
|
160
Hilton Grand Vacations
HGV
$4.16B
| $218K | 0.06% |
+5,244
| New | +$218K |
|
161
ChargePoint
CHPT
$250M
| $211K | 0.06% |
+300,357
| New | +$211K |
|
162
Generac Holdings
GNRC
$10.4B
| $205K | 0.06% |
+1,433
| New | +$205K |
|
163
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $204K | 0.06% |
+1,517
| New | +$204K |
|
164
BlackLine
BL
$3.34B
| $200K | 0.06% |
+3,533
| New | +$200K |
|
165
Ocugen
OCGN
$315M
| $195K | 0.06% |
+200,783
| New | +$195K |
|
166
Lumen
LUMN
$4.92B
| $194K | 0.06% |
+44,178
| New | +$194K |
|
167
FIGS
FIGS
$1.07B
| $184K | 0.05% |
+32,640
| New | +$184K |
|
168
Dynavax Technologies
DVAX
$1.19B
| $180K | 0.05% |
+18,186
| New | +$180K |
|
|
IAUX
169
i-80 Gold Corp
IAUX
$669M
| $135K | 0.04% |
+225,991
| New | +$135K |
|
170
Oric Pharmaceuticals
ORIC
$999M
| $120K | 0.04% |
+11,868
| New | +$120K |
|
171
American Express Global Business Travel
GBTG
$3.91B
| $120K | 0.04% |
+18,985
| New | +$120K |
|
172
Ocular Therapeutix
OCUL
$2.17B
| $106K | 0.03% |
+11,467
| New | +$106K |
|
173
Aurinia Pharmaceuticals
AUPH
$1.55B
| $100K | 0.03% |
+11,822
| New | +$100K |
|
|
GOGL
174
DELISTED
Golden Ocean Group
GOGL
| $94.9K | 0.03% |
+12,969
| New | +$94.9K |
|
175
SES AI
SES
$399M
| $90.8K | 0.03% |
+102,207
| New | +$90.8K |
|